IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q4 2025 Holdings

Filed 2026-02-17 | 12 holdings | $369.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vanguard Intl Equity Index F(VEU)ALLWRLD EX US922042775$220.0M2,990,08459.5%
Vanguard Index FDS(VTV)VALUE ETF922908744$99.3M520,00026.9%
Ishares TR(INDA)MSCI INDIA ETF46429B598$20.0M369,6005.4%
Foghorn Therapeutics Inc(FHTX)COM344174107$8.5M1,573,7612.3%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$8.1M989,4102.2%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$3.3M2,627,6430.9%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$2.8M4,1040.8%
Rapt Therapeutics Inc(RAPT)COM NEW75382E208$2.8M82,2340.8%
Alector Inc(ALEC)COM014442107$2.0M1,307,8580.6%
Surrozen Inc(SRZN)COM NEW86889P208$2.0M87,6960.5%
Tenaya Therapeutics Inc(TNYA)COM87990A106$722.7K1,015,7050.2%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$3.4K170,8330.0%